Global Hashimoto’s Thyroiditis Market Research and Forecast, 2018-2023
Hashimoto’s thyroiditis is a condition in which the immune system attacks the thyroid and gradually leads to hyperthyroidism. Production of immune cells and autoantibodies by the body’s immune system are characteristics of Hashimoto’s thyroiditis, which can damage thyroid cells and compromise their ability to make thyroid hormone. There are various treatment methods for such diseases by using replacement agents such as levothyroxine, triiodothyronine or desiccated thyroid extract. The increasing autoimmune thyroid diseases and deficiency of iodine are responsible for the growth of Hashimoto’s Thyroiditis treatment market. Moreover, the increasing exposure to harmful radiation is spreading more diseases which can fuel the growth of this market. furthermore, there are various national health programs related to thyroid disease that raise awareness regarding such diseases that further fuel the growth of the Hashimoto’s thyroiditis market.
However, there are stringent regulation of Food and drug administration regarding medication of Hashimoto’s Thyroiditis which act as an obstacle for the market and in addition, the treatment is very prolonged. Although the research and development for any kind of disorder such as Hashimoto’s diseases and the cost-effectiveness of the treatment will turn out to be a huge opportunity for the adoption of Hashimoto’s Thyroiditis Treatment.
Geographically market is divided into North America, Europe, Asia Pacific and Rest of the World. North America region is growing with a significant growth and is dominating the overall global Hashimoto’s Thyroiditis market due to the increasing prevalence of autoimmune thyroid diseases in the US. In addition, the research and development activities in the North American region further fuel the growth of the market. moreover, Asia Pacific is expected to have the highest CAGR during the forecast period 2018-2023. The development of cost-effective treatment and the increasing healthcare investment is the driving factor for Hashimoto’s Thyroiditis market in the Asia Pacific region.
There are many companies which are in Hashimoto’s Thyroiditis market such as Merck KGaA, Novartis International AG, Pfizer, Inc, Sanofi Genzyme, Azico Pharmaceuticals Pvt. Ltd., Jerome Stevens Pharmaceuticals, Inc. Lupin Ltd. and so on. The companies are working on developing Hashimoto’s Thyroiditis medication or drug and research, expansion M&A, finding a new market or innovate in their core competency in order to expand individual market share.
RESEARCH METHODOLOGY
The market study of Hashimoto’s Thyroiditis market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analysing various regional players, regional tax laws and policies, consumer behaviour and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
SECONDARY SOURCES INCLUDE
MARKET SEGMENTATION
Global Hashimoto’s Thyroiditis market is segmented on the basis of regional outlook and following segments:
1. Global Hashimoto’s Thyroiditis Market Research and Analysis, By Diagnosis
2. Global Hashimoto’s Thyroiditis Market Research and Analysis, By Treatment
3. Global Hashimoto’s Thyroiditis Market Research and Analysis, By Distribution Channel
THE REPORT COVERS
However, there are stringent regulation of Food and drug administration regarding medication of Hashimoto’s Thyroiditis which act as an obstacle for the market and in addition, the treatment is very prolonged. Although the research and development for any kind of disorder such as Hashimoto’s diseases and the cost-effectiveness of the treatment will turn out to be a huge opportunity for the adoption of Hashimoto’s Thyroiditis Treatment.
Geographically market is divided into North America, Europe, Asia Pacific and Rest of the World. North America region is growing with a significant growth and is dominating the overall global Hashimoto’s Thyroiditis market due to the increasing prevalence of autoimmune thyroid diseases in the US. In addition, the research and development activities in the North American region further fuel the growth of the market. moreover, Asia Pacific is expected to have the highest CAGR during the forecast period 2018-2023. The development of cost-effective treatment and the increasing healthcare investment is the driving factor for Hashimoto’s Thyroiditis market in the Asia Pacific region.
There are many companies which are in Hashimoto’s Thyroiditis market such as Merck KGaA, Novartis International AG, Pfizer, Inc, Sanofi Genzyme, Azico Pharmaceuticals Pvt. Ltd., Jerome Stevens Pharmaceuticals, Inc. Lupin Ltd. and so on. The companies are working on developing Hashimoto’s Thyroiditis medication or drug and research, expansion M&A, finding a new market or innovate in their core competency in order to expand individual market share.
RESEARCH METHODOLOGY
The market study of Hashimoto’s Thyroiditis market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analysing various regional players, regional tax laws and policies, consumer behaviour and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
SECONDARY SOURCES INCLUDE
- Financial reports of companies involved in the market
- Authentic Public Databases such as the WHO, American Thyroid Association and others.
- Whitepapers, research-papers and news blogs
- Company websites and their product catalogue.
MARKET SEGMENTATION
Global Hashimoto’s Thyroiditis market is segmented on the basis of regional outlook and following segments:
1. Global Hashimoto’s Thyroiditis Market Research and Analysis, By Diagnosis
2. Global Hashimoto’s Thyroiditis Market Research and Analysis, By Treatment
3. Global Hashimoto’s Thyroiditis Market Research and Analysis, By Distribution Channel
THE REPORT COVERS
- Comprehensive research methodology of global Hashimoto’s thyroiditis market
- This report also includes detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global Hashimoto’s thyroiditis market.
- Insights about market determinants which are stimulating the global Hashimoto’s thyroiditis market
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATION
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING PREVALENCE OF AUTOIMMUNE THYROID DISEASES
3.1.2. INCREASING PREVALENCE OF GENETIC THYROID DISORDER
3.1.3. DETERIORATING LIFESTYLE
3.1.4. NATIONAL HEALTH PROGRAMS RELATED TO THYROID
3.2. RESTRAINTS
3.2.1. AVAILABILITY OF ALTERNATE TREATMENT OPTIONS SUCH AS REMEDIAL HERBS AND ACUPUNCTURE
3.2.2. STRINGENT GOVERNMENT REGULATIONS RELATED TO MEDICATION OF HASHIMOTO’S THYROIDITIS
3.3. OPPORTUNITIES
3.3.1. COST EFFECTIVENESS OF TREATMENT
3.3.2. R&D FOR MANY KINDS OF DISORDER SUCH AS HASHIMOTO’S DISEASES
4. MARKET SEGMENTATION
4.1. GLOBAL HASHIMOTO’S THYROIDITIS TREATMENT MARKET, BY DIAGNOSIS
4.1.1. THYROID-STIMULATING HORMONE TEST
4.1.2. THYROXINE TEST
4.1.3. ANTITHYROID ANTIBODY TEST
4.2. GLOBAL HASHIMOTO’S THYROIDITIS MARKET, BY TREATMENT
4.2.1. LEVOTHYROXINE
4.2.2. TRIIODOTHYRONINE
4.2.3. DESICCATED THYROID EXTRACT
4.3. GLOBAL HASHIMOTO’S THYROIDITIS MARKET, BY DISTRIBUTION CHANNEL
4.3.1. HOSPITAL PHARMACIES
4.3.2. RETAIL PHARMACIES
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. UK
6.2.2. GERMANY
6.2.3. SPAIN
6.2.4. FRANCE
6.2.5. ITALY
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. REST OF ASIA PACIFIC
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ABBVIE INC.
7.2. AKRIMAX PHARMACEUTICALS LLC
7.3. ALLERGAN PLC
7.4. GLAXOSMITHKLINE PLC
7.5. INTAS PHARMACEUTICALS LTD.
7.6. JEROME STEVENS PHARMACEUTICALS, INC.
7.7. LANNETT COMPANY, INC.
7.8. LLOYD INC.
7.9. LLOYD, INC.
7.10. LUPIN LTD
7.11. LUPIN LTD.
7.12. MERCK KGAA
7.13. MERCK KGAA,
7.14. MYLAN N.V.
7.15. NOVARTIS INTERNATIONAL AG
7.16. PFIZER INC
7.17. SANOFI GENZYME
7.18. TAJ PHARMACEUTICALS LIMITED
7.19. WOCKHARDT LTD.
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATION
2.3.1. UNITED STATES
2.3.2. EUROPEAN UNION
2.3.3. CHINA
2.3.4. INDIA
3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING PREVALENCE OF AUTOIMMUNE THYROID DISEASES
3.1.2. INCREASING PREVALENCE OF GENETIC THYROID DISORDER
3.1.3. DETERIORATING LIFESTYLE
3.1.4. NATIONAL HEALTH PROGRAMS RELATED TO THYROID
3.2. RESTRAINTS
3.2.1. AVAILABILITY OF ALTERNATE TREATMENT OPTIONS SUCH AS REMEDIAL HERBS AND ACUPUNCTURE
3.2.2. STRINGENT GOVERNMENT REGULATIONS RELATED TO MEDICATION OF HASHIMOTO’S THYROIDITIS
3.3. OPPORTUNITIES
3.3.1. COST EFFECTIVENESS OF TREATMENT
3.3.2. R&D FOR MANY KINDS OF DISORDER SUCH AS HASHIMOTO’S DISEASES
4. MARKET SEGMENTATION
4.1. GLOBAL HASHIMOTO’S THYROIDITIS TREATMENT MARKET, BY DIAGNOSIS
4.1.1. THYROID-STIMULATING HORMONE TEST
4.1.2. THYROXINE TEST
4.1.3. ANTITHYROID ANTIBODY TEST
4.2. GLOBAL HASHIMOTO’S THYROIDITIS MARKET, BY TREATMENT
4.2.1. LEVOTHYROXINE
4.2.2. TRIIODOTHYRONINE
4.2.3. DESICCATED THYROID EXTRACT
4.3. GLOBAL HASHIMOTO’S THYROIDITIS MARKET, BY DISTRIBUTION CHANNEL
4.3.1. HOSPITAL PHARMACIES
4.3.2. RETAIL PHARMACIES
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.2. KEY COMPANY ANALYSIS
6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. UK
6.2.2. GERMANY
6.2.3. SPAIN
6.2.4. FRANCE
6.2.5. ITALY
6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. REST OF ASIA PACIFIC
6.4. REST OF THE WORLD
7. COMPANY PROFILES
7.1. ABBVIE INC.
7.2. AKRIMAX PHARMACEUTICALS LLC
7.3. ALLERGAN PLC
7.4. GLAXOSMITHKLINE PLC
7.5. INTAS PHARMACEUTICALS LTD.
7.6. JEROME STEVENS PHARMACEUTICALS, INC.
7.7. LANNETT COMPANY, INC.
7.8. LLOYD INC.
7.9. LLOYD, INC.
7.10. LUPIN LTD
7.11. LUPIN LTD.
7.12. MERCK KGAA
7.13. MERCK KGAA,
7.14. MYLAN N.V.
7.15. NOVARTIS INTERNATIONAL AG
7.16. PFIZER INC
7.17. SANOFI GENZYME
7.18. TAJ PHARMACEUTICALS LIMITED
7.19. WOCKHARDT LTD.
LIST OF TABLES
TABLE # 1 GLOBAL HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-20232017-2023($ MILLION)
TABLE # 2 GLOBAL THYROID-STIMULATING HORMONE TEST MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 3 GLOBAL THYROXINE TEST MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 4 GLOBAL ANTITHYROID ANTIBODY TEST MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 5 2017-20232017-2023GLOBAL HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-20232017-2023($ MILLION)
TABLE # 6 GLOBAL LEVOTHYROXINE MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 7 GLOBAL TRIIODOTHYRONINE MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 8 GLOBAL DESICCATED THYROID EXTRACT MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 9 GLOBAL HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-20232017-2023($ MILLION)
TABLE # 10 GLOBAL HOSPITAL PHARMACIES MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE # 11 GLOBAL RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE # 12 NORTH AMERICA HASHIMOTO'S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 13 NORTH AMERICA HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-20232017-2023($ MILLION)
TABLE # 14 NORTH AMERICA HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-20232017-2023($ MILLION)
TABLE # 15 NORTH AMERICA HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023($ MILLION)
TABLE # 16 EUROPE HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 17 EUROPE HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 18 EUROPE HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-20232017-2023($ MILLION)
TABLE # 19 EUROPE HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-20232017-2023($ MILLION)
TABLE # 20 ASIA PACIFIC HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 21 ASIA PACIFIC HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 22 ASIA PACIFIC HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-20232017-2023($ MILLION)
TABLE # 23 ASIA PACIFIC HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-20232017-2023($ MILLION)
TABLE # 24 ROW HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-20232017-2023 ($ MILLION)
TABLE # 25 ROW HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 26 ROW HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
TABLE # 1 GLOBAL HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-20232017-2023($ MILLION)
TABLE # 2 GLOBAL THYROID-STIMULATING HORMONE TEST MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 3 GLOBAL THYROXINE TEST MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 4 GLOBAL ANTITHYROID ANTIBODY TEST MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 5 2017-20232017-2023GLOBAL HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-20232017-2023($ MILLION)
TABLE # 6 GLOBAL LEVOTHYROXINE MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 7 GLOBAL TRIIODOTHYRONINE MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 8 GLOBAL DESICCATED THYROID EXTRACT MARKET RESEARCH AND ANALYSIS, 2017-20232017-2023($ MILLION)
TABLE # 9 GLOBAL HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-20232017-2023($ MILLION)
TABLE # 10 GLOBAL HOSPITAL PHARMACIES MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE # 11 GLOBAL RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS, 2017-2023($ MILLION)
TABLE # 12 NORTH AMERICA HASHIMOTO'S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 13 NORTH AMERICA HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-20232017-2023($ MILLION)
TABLE # 14 NORTH AMERICA HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-20232017-2023($ MILLION)
TABLE # 15 NORTH AMERICA HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023($ MILLION)
TABLE # 16 EUROPE HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 17 EUROPE HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 18 EUROPE HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-20232017-2023($ MILLION)
TABLE # 19 EUROPE HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-20232017-2023($ MILLION)
TABLE # 20 ASIA PACIFIC HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
TABLE # 21 ASIA PACIFIC HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023($ MILLION)
TABLE # 22 ASIA PACIFIC HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-20232017-2023($ MILLION)
TABLE # 23 ASIA PACIFIC HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-20232017-2023($ MILLION)
TABLE # 24 ROW HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-20232017-2023 ($ MILLION)
TABLE # 25 ROW HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
TABLE # 26 ROW HASHIMOTO’S THYROIDITIS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
